Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

by Silvia Ratto-Kim, Jeffrey R Currier, Josephine H Cox, Jean-Louis Excler, Anais Valencia-Micolta, Doris Thelian, Vicky Lo, Eddy Sayeed, Victoria R Polonis, Patricia L Earl, Bernard Moss, Merlin L Robb, Nelson L Michael, Jerome H Kim, Mary A Marovich
Published 2012-01-01